European Journal of Medicinal Chemistry p. 420 - 426 (2014)
Update date:2022-08-05
Topics:
Sun, Juan
Lv, Peng-Cheng
Guo, Feng-Jiao
Wang, Xin-Yi
Han, Xiao-
Zhang, Yang
Sheng, Gui-Hua
Qian, Shao-Song
Zhu, Hai-Liang
A novel class of aromatic diacylhydrazine derivatives was designed as PLK1 inhibitors. All the 19 new synthesized compounds were assayed for antitumor activity against the respective cervical cancer cells. In which, nine compounds with better antitumor activities were further tested for their PLK1 inhibitory activity. Last, we have successfully found that compound 7k showed both the promising antitumor activity with IC50 of 0.17 μM against the cervical cancer cells, and also processed the most potent PLK1 inhibitory activity with IC50 of 0.03 μM. In addition, docking simulation also carried out in this study to give a potent prediction binding mode between the small molecule and PKL1 (PDB code: 1umw) protein.
View MoreShanghai Maxchemco Chemical Industry Co., Ltd.
Contact:(86)21-51079223
Address:No.1305-8, B241, the Ecust Park, Huajing Road, Xuhui District, Shanghai
Qingdao S. H. Huanyu Imp. & Exp. Co., Ltd.
Contact:86-532-88250866
Address:Room 615, World Trade Centre Building B, Hongkong Middle Roda 6#, Qingdao, Shandong, China
jiangsu senxuan pharmaceutical and chemical co.,ltd
Contact:86-523-87982810
Address:hongqiao industrial zone,taixing,jiangsu china
Shouguang Nuomeng Chemical Co., Ltd.
Contact:+86-536-5119508/18363669993
Address:Hou Zhen Industrial Park, Shouguang, Shandong, China
xi'an taima biological engineering co., ltd.
Contact:+8615619038117
Address:6 No,keji road xi'an city of china
Doi:10.1016/S0040-4020(01)92551-7
(1967)Doi:10.1039/c4tc00317a
(2014)Doi:10.1002/ejoc.201301874
(2014)Doi:10.1039/c4dt00600c
(2014)Doi:10.1016/0040-4039(94)02399-V
(1995)Doi:10.1246/bcsj.68.554
(1995)